{"schema_version":"secwatch.filing_event.v1","accession":"0000805928-26-000104","form_type":"8-K","ticker":"AXGN","cik":"0000805928","company_name":"Axogen, Inc.","filed_at":"2026-10-01T21:25:33+00:00","discovered_at":"2026-10-01T21:26:00.266972+00:00","generated_at":"2026-10-12T14:28:56.658717+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Axogen closes BioCircuit acquisition, adding FDA-cleared NerveTape; sees ~$34M 2027 revenue contribution","bullets":["Axogen completed its acquisition of privately held BioCircuit Technologies, Inc. on October 1, 2026, adding NerveTape, described as the first FDA-cleared device for sutureless peripheral nerve repair.","BioCircuit expected to contribute approximately $6 million to Q4 2026 revenue and approximately $34 million to 2027 revenue.","That contribution was not included in Axogen's most recently issued full-year 2026 guidance of at least 24% revenue growth.","Company continues to expect full-year 2026 gross margin of at least 73% and to be free cash flow positive.","CEO Michael Dale said NerveTape is 'simpler, faster, and more effective than microsuturing' and fits Axogen's direct sales and hospital contracting; purchase price not disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0000805928-26-000104","json":"https://secwatch.observer/filing/0000805928-26-000104.json","markdown":"https://secwatch.observer/filing/0000805928-26-000104.md","text":"https://secwatch.observer/filing/0000805928-26-000104.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000104/0000805928-26-000104-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000104/axgn-20261001.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:28:56.658717+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}